Republicans, including Sen. Josh Hawley, have showcased recent studies they say prove complications are potentially 22 times higher than data used by the FDA.

Four blue states are asking the U.S. Food and Drug Administration to remove restrictions on a key abortion medication and ...

Below is a list of U.S. regulators who oversee Musk's companies, including automaker Tesla, rocket and satellite company ...

Neil Young once sang of adapting to a world ruled by data and digital minds in “Computer Age.” Today, that vision feels increasingly real as the ...

Health and Human Services Secretary Robert F. Kennedy Jr. said on Thursday that the U.S. drugs regulator would look for ways ...

A brand of crackers is recalling one of its products sold at stores in 11 states, including Massachusetts, because it may ...

This week on "The Readout LOUD" podcast: an AI experiment at the FDA and how Novo Nordisk is trailing in the obesity drug ...

Rice is a staple ingredient in so many different dishes, so it's a serious issue when it's recalled. Here are some of the ...

California, Massachusetts, New York and New Jersey petitioned the U.S. Food and Drug Administration on Thursday to ease its ...

The Food and Drug Administration issued Class I recalls, the most serious type, for two Smiths Medical infusion pumps due to the potential for serious injury or death.

The Food and Drug Administration (FDA) cleared the first blood test recently to help diagnose Alzheimer's disease.

Kura Oncology and Kyowa Kirin submitted data from the KOMET-001 trial, which the agency will review and decide whether to approve the drug by Nov. 30.